Kodiak Sciences Inc (KOD)
3.94
+0.17
(+4.51%)
USD |
NASDAQ |
May 06, 16:00
3.95
+0.01
(+0.25%)
After-Hours: 20:00
Kodiak Sciences Total Liabilities (Quarterly): 213.59M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 213.59M |
| September 30, 2023 | 245.24M |
| June 30, 2023 | 251.18M |
| March 31, 2023 | 247.75M |
| December 31, 2022 | 230.46M |
| September 30, 2022 | 244.46M |
| June 30, 2022 | 250.97M |
| March 31, 2022 | 252.90M |
| December 31, 2021 | 240.90M |
| September 30, 2021 | 231.89M |
| June 30, 2021 | 218.17M |
| March 31, 2021 | 211.06M |
| Date | Value |
|---|---|
| December 31, 2020 | 206.60M |
| September 30, 2020 | 198.96M |
| June 30, 2020 | 120.17M |
| March 31, 2020 | 115.36M |
| December 31, 2019 | 13.51M |
| September 30, 2019 | 9.225M |
| June 30, 2019 | 8.256M |
| March 31, 2019 | 6.982M |
| December 31, 2018 | 5.356M |
| September 30, 2018 | 110.94M |
| June 30, 2018 | 5.046M |
| December 31, 2017 | 71.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.256M
Minimum
Jun 2019
252.90M
Maximum
Mar 2022
184.77M
Average
218.17M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 13.69M |
| Regeneron Pharmaceuticals Inc | 7.378B |
| iBio Inc | 24.82M |
| Puma Biotechnology Inc | 163.17M |
| Dare Bioscience Inc | 26.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 479.37M |
| Shareholders Equity (Quarterly) | 265.78M |